<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">CNR</journal-id><journal-title-group><journal-title>Clinical Neuroscience Research</journal-title></journal-title-group><issn>3083-4899</issn><eissn>2981-8133</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/cnr.v3i2.11153</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Analysis of the Therapeutic Effect of Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion</title><url>https://artdesignp.com/journal/CNR/3/2/10.26689/cnr.v3i2.11153</url><author>LuZhigang,LiuJingjing,LiuQiang,JianHuifeng</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>3</volume><issue>2</issue><history><date date-type="pub"><published-time>2025-05-28</published-time></date></history><abstract>Objective: This study aims to investigate the clinical efficacy of intra-arterial thrombolysis (IAT) in the treatment of acute central retinal artery occlusion (CRAO) and to provide evidence for optimizing treatment strategies. Methods: A retrospective analysis was conducted on 29 CRAO patients treated between January 2024 and December 2024. Among them, 18 patients received intra-arterial thrombolysis, 6 patients received intravenous thrombolysis, and 5 patients received conventional treatment. Baseline characteristics, visual acuity recovery, and complication rates were compared among the three groups. SPSS 26.0 was used for statistical analysis. Results: The improvement in visual acuity at 24 hours in the intra-arterial thrombolysis group (ΔLogMAR=1.4) was significantly better than that in the intravenous tPA group (ΔLogMAR=1.2) and the conservative treatment group (ΔLogMAR=0.5). The most significant improvement in visual acuity at 30 days postoperatively was observed in the intra-arterial thrombolysis group (ΔLogMAR=1.2 ± 0.4), which was significantly better than that in the intravenous tPA group (ΔLogMAR=0.8 ± 0.3) and the conservative treatment group (ΔLogMAR=0.3 ± 0.2) (P&amp;lt;0.01). There was no significant difference in complication rates among the three groups (P&amp;gt;0.05). Conclusion: This study confirms that intra-arterial thrombolysis can effectively improve visual function and retinal blood perfusion in CRAO patients with good safety, providing a new evidence-based approach for clinical treatment. Future studies with larger sample sizes are needed to further validate its long-term efficacy.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Mac Grory B, Nackenoff A, Poli S, et al., 2020, Intravenous Fibrinolysis for Central Retinal Artery Occlusion: A Cohort Study and Updated Patient-level Meta-analysis. Stroke, 51(7): 2018–2025.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Lee D, Tomita Y, Miwa Y, et al., 2021, Fenofibrate Protects against Retinal Dysfunction in a Murine Model of Common Carotid Artery Occlusion-induced Ocular Ischemia. Pharmaceuticals (Basel), 14(3): 223.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Varma DD, Cugati S, Lee AW, et al., 2013, A Review of Central Retinal Artery Occlusion: Clinical Presentation and Management. Eye (London), 27(6): 688–697.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Kim SH, 2022, Hyperbaric Oxygen Therapy in CRAO: A Randomized Controlled Trial. Ophthalmology, 129(6): 654–662.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Nedelmann M, Graef M, Weinand F, et al., 2015, Retrobulbar Spot Sign Predicts Thrombolytic Treatment Effects and Etiology in Central Retinal Artery Occlusion. Stroke, 46(8): 2322–2324.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Chinese Research Hospital Association Neuro-Ophthalmology Professional Committee, 2024, Chinese Expert Consensus on Clinical Diagnosis and Treatment of Central Retinal Artery Occlusion. Chinese Journal of Stroke, 19(11): 1247–1267.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Li YJ, Zhang T, 2023, Observation on the Effect of Ultra-selective Ophthalmic Artery Interventional Thrombolysis in the Treatment of Central Retinal Artery Occlusion. Chinese Journal of Fundus Diseases, 39(7): 521–525.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Nie DA, Shen YF, Jiao LQ, et al., 2015, Efficacy of Superselective Ophthalmic Artery Thrombolysis in Central Retinal Artery Occlusion within Different Time Windows. Journal of Clinical Neurology, 28(3): 221–223.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Department of Ophthalmology, Xi’an People’s Hospital, 2020, Comparative Observation of the Efficacy of Urokinase Arterial Thrombolysis at Different Time Windows in the Treatment of Central Retinal Artery Occlusion. Chinese Journal of Fundus Diseases, 36(10): 785–790.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Chen J, 2018, Observation on the Effect of 40 Cases of Ultra-selective Ophthalmic Artery Thrombolysis in the Treatment of Central Retinal Artery Embolism. Chinese Journal of Ophthalmology and Otorhinolaryngology, 18(3): 189–192.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Tan H, 2017, Initial Exploration of Nursing Intervention for Thrombolytic Therapy of Cerebral Infarction at Different Time Windows. Journal of Nursing Science, 32(3): 45–48.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Department of Ophthalmology, First Affiliated Hospital of Gannan Medical University, 2024, Case Report of Intravitreal Injection of Alteplase for the Treatment of Retinal Artery Occlusion. Chinese Journal of Experimental Ophthalmology, 42(6): 512–515.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
